FIELD: pharmaceutical composition.
SUBSTANCE: invention is related to N-(1H-imidazol-2-yl)benzamide of formula (I), where the values of R1-R 4, A, X are defined in the formula of the invention, or a pharmaceutically acceptable salt or stereoisomer thereof, which has inhibitory activity in relation to IRAK-4.
EFFECT: used for the effective prevention and treatment of diseases mediated by IRAK-4 receptors, in particular autoimmune diseases or lymphomas.
19 cl, 26 tbl, 303 ex
| Title |
Year |
Author |
Number |
| BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS |
2006 |
- Kao Zhianguo
- Khud Dzhon
- Lokhs Deniel
- Mak Chi Ching
- Mak Ferson Endryu
- Norona Glenn
- Petek Ved
- Renik Dzhoel
- Soll Richard M.
- Zeng Binki
|
RU2597364C2 |
| BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS |
2006 |
- Kao Zhianguo
- Khud Dzhon
- Lokhs Deniel
- Mak Chi Ching
- Mak Ferson Endryu
- Norona Glenn
- Petek Ved
- Renik Dzhoel
- Soll Richard M.
- Zeng Binki
|
RU2589878C2 |
| TRKA KINASE INHIBITORS, COMPOSITIONS BASED THEREON AND METHODS |
2015 |
- Mitchell Khelen
- Freli Mark E.
- Kuk Endryu Dzh.
- Chen I-Khen
- Stamp Krejg A.
- Chzhan Syuj-Fan
- Makkomas Kejsi S.
- Shirripa Keti
- Makverter Melodi
- Merser Svati P.
- Babaoglu Kerim
- Men Dunfan
- Vu Dzhejn
- Lyu Pin
- Vud Kharold B.
- Bao Tszyanmin
- Li Chun Sing
- Mao Tsinkhua
- Tsi Chzhitsi
|
RU2672583C2 |
| 6-HETEROCYCLYL-4-MORPHOLINE-4-ILPYRIDINE-2-ONES SUITABLE FOR THE TREATMENT OF CANCER AND DIABETES |
2017 |
- Martinsson, Dzhessika
- Andersson, Martin
- Lindstrem, Jokhan
- Forsblom, Rikard
- Ram, Fredrik
- Jinman, Tobias
- Viklund, Jenni
|
RU2762968C2 |
| MENIN-MLL INTERACTION INHIBITORS |
2017 |
- Kakatyan Salvasion
- Klejrmon Devid A.
- Dillard Lourens Vejn
- Dun Chengo
- Fan I
- Tszya Lantsi
- Lotesta Stefen D.
- Markus Endryu
- Morales-Ramos Enzhel
- Singkh Suresh B.
- Venkatraman Shankar
- Yuan Tszin
- Chzhen Yatszyun
- Chzhuan Linkhan
- Perent Stefan D.
- Khyuston Trejvis L.
|
RU2799820C2 |
| DERIVATIVE OF CARBOXYLIC ACID WITH CONDENSED RINGS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1997 |
- Tagami Katsuja
- Esimura Khirojuki
- Nagai Mitsuo
- Khibi Sigeki
- Kikuti Kouiti
- Sato Takasi
- Okita Makoto
- Okamoto Jasusi
- Nagasaka Jumiko
- Kobajasi Naoki
- Khida Takajuki
- Tai Kendzi
- Tokukhara Naoki
- Kobajasi Seiiti
|
RU2195448C2 |
| PRIMARY CARBOXAMIDES AS BTK INHIBITORS |
2014 |
- Bonafu Dominik
- Devis Khiter M.
- Frenk Kristin E.
- Fridman Majkl M.
- Kherold Dzh. Martin
- Khoumann Majkl Z.
- Khantli Rejmond
- Osuma Ogastin
- Sheppard Dzhordzh
- Somal Gagandip K.
- Van Kamp Dzhennifer
- Van Epps Stejsi A.
- Vasudevan Anil
- Uollejs Grir A.
- Van Lu
- Van Lu
- Van Chzhi
- Uilson Noel S.
- Syuj Syandun
|
RU2708395C2 |
| CYCLIC CYANOENONE DERIVATIVES AS KEAP1 MODULATORS |
2021 |
- Altman, Michael
- Candito, David, A.
- Christian, Alec, H.
- Di Pietro, Ornella
- Lu, Min
- Liu, Ping
- Mansoor, Umar, Faruk
- Mennie, Katrina, Marie
- Musacchio, Andrew, J.
- Palani, Anandan
- Reutershan, Michael, H.
- Shaw, David, Matthew
- St-Gallay, Stephen
|
RU2822828C1 |
| GCN2 INHIBITORS AND THEIR USE |
2019 |
- Bayly, Andrew
- Bleich, Matthew
- Charrier, Jean-Damien
- Dodd, James
- Durrant, Steven
- Eno, Meredith Suzanne
- Etxebarria I Jardi, Gorka
- Everitt, Simon
- Fraysse, Damien
- Kelly, Shazia
- Knegtel, Ronald
- Mochalkin, Igor
- Mortimore, Michael
- North, Kiri
- Porichis, Filippos
- Pullin, Robert
- Rutherford, Alistair
- Storck, Pierre-Henri
- Twin, Heather Clare
- Xiao, Yufang
|
RU2811408C2 |
| COMBINATION CONTAINING NEW DERIVATIVE 3-(4-(BENZYLOXY)PHENYL)HEX-4-IN-ACID AND OTHER ACTIVE INGREDIENT TO ACTIVATE G-PROTEIN 40 OF THE RECEPTOR ENZYME |
2015 |
- Yan Dzhin
- Kim Dzhin Voon
- Li Khan Kyu
- Kim Dzhe Khyun
- Son Chan Mo
- Li Kyu Khvan
- Choj Khyun-Kho
- Kim Dekhoon
- Kha Te-Eun
- Rkhee Dzhekol
|
RU2680248C1 |
